Home
Aavis Pharmaceuticals

Aavis Pharmaceuticals Market Share Analysis for June 2026

Industry: N/A

Domainaavispharmaceuticals.com

Year Founded2015

Employees51 - 200

Annual Revenue$10M - $15M

Aavis Pharmaceuticals

Aavis Pharmaceuticals (including company regionals)

aavispharmaceuticals.com

See more website traffic and engagement information

Aavis Pharmaceuticals Revenue up to June 2026 is 10M - 15M

revenue generated by Aavis Pharmaceuticals top domains

Aavis Pharmaceuticals top domains revenue over 3 years

Revenue for Aavis Pharmaceuticals top domains

aavispharmaceuticals.com10M - 15M

See more with Sales Intelligence

Total visits to Aavis Pharmaceuticals's top domains

Understand Aavis Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aavispharmaceuticals.com766

See more with Sales Intelligence

Avg. visit duration in Aavis Pharmaceuticals's top domains

Analyze Aavis Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aavispharmaceuticals.com--

See more with Sales Intelligence

Avg. pageviews on Aavis Pharmaceuticals's top domains

See how Aavis Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aavispharmaceuticals.com1.04

See more with Sales Intelligence

Aavis Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Aavis Pharmaceuticals

These are the website technologies, by industry, used by Aavis Pharmaceuticals top domains

eCommerce (1)

Swap

Email Services (1)

GoDaddy Email

Mobile (1)

Meta Viewport

Other (1)

Google API

More Technologies

1

See all

News & Signals from Aavis Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAavis Pharmaceuticals hires Gautam Shah as President of U.S. Operations.D/B/A Aavis Pharmaceuticals, has announced the appointment of Gautam Shah as President of U.S. Operations.

NewsAavis Pharmaceuticals launches Hydroxychloroquine Sulfate tablets, 200 mg, a therapeutic equivalent version of Plaquenil 200 mg in the U.S. market.Jubilant Pharma Ltd. and Aavis Pharmaceuticals Inc. announce the launch of Hydroxychloroquine Sulfate tablets, 200 mg, a therapeutic equivalent version of Plaquenil (hydroxychloroquine sulfate) 200 mg in the U.S. market.